Soft tissue sarcoma

Related records

Broader conditions (11)

• Cancer
• Cancer or benign tumor
• Connective and soft tissue neoplasm
• Disease
• Disease by etiologic mechanism
• Human disease
• Malignant soft tissue neoplasm
• Neoplasm
• Neoplastic disease or syndrome
• Sarcoma
• Soft tissue neoplasm

Narrower conditions (245)

• Adult botryoid rhabdomyosarcoma
• Adult epithelioid sarcoma
• Adult extraskeletal osteosarcoma
• Adult fibrosarcoma
• Adult liposarcoma
• Adult malignant schwannoma
• Adult pleomorphic rhabdomyosarcoma
• Adult vagina botryoid embryonal rhabdomyosarcoma
• Alveolar rhabdomyosarcoma
• Alveolar soft part sarcoma
• Anaplastic sarcoma of the kidney
• Angiosarcoma
• Angiosarcoma of the scalp
• Anus leiomyosarcoma
• Anus rhabdomyosarcoma
• Anus sarcoma
• Aorta angiosarcoma
• Atypical teratoid rhabdoid tumor
• Atypical teratoid rhabdoid tumor, MYC-activated
• Atypical teratoid rhabdoid tumor, SHH-activated

Trials (548)

• "Exercise Intervention to Increase Physical Activity in Young Sarcoma Survivors (Sport Ist Herzenssache)"
• (SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas
• 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma
• 5-Day Preoperative Radiation for Soft Tissue Sarcoma
• 68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
• 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
• 89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and Soft Tissue Sarcoma
• A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma
• A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
• A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
• A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
• A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
• A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma
• A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma
• A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
• a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
• A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece
• A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.
• A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
• A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Approved drugs (4)

• Doxorubicin hydrochloride
• Olaratumab
• Pazopanib hydrochloride
• Trabectedin

Drugs in development (129)

• [18F]FLUOROMISONIDAZOLE Phase 1
• Afamitresgene autoleucel Phase 2
• Albumin human Phase 1
• Aldoxorubicin Phase 3
• Aminolevulinic acid Phase 1
• Amrubicin Phase 2
• Antineoplaston A10 Phase 2
• Ascorbic acid Phase 1
• Axitinib Phase 2
• Balstilimab Phase 2
• Belinostat Phase 1
• Bendamustine Phase 2
• Bevacizumab Phase 2
• Bintrafusp alfa Phase 2
• Bupivacaine Early phase 1
• Cabozantinib Phase 2
• Cabozantinib S-malate Phase 1
• Cadonilimab Phase 2
• Camrelizumab Phase 2
• Camsirubicin Phase 2